OMRON Healthcare and Servier announce a long-term strategic partnership to jointly innovate hypertension management aiming to reduce the number of cardiovascular events such as heart attacks and strokes.
Paris, France, March 14th, 2023 – OMRON Healthcare Europe and Servier today announced a long-term strategic partnership that aims to bring about innovations that will improve the identification, management, and long-term control of hypertension and other cardiovascular conditions, with the ultimate objective of improving the lives of patients worldwide.
The partnership between OMRON Healthcare and Servier is based on a shared vision of improving lives and contributing to a better society through the translation of science and technology into improved cardiovascular disease treatment and prevention. Through this agreement, the two companies will combine their respective strengths in medicine and technology to transform the way hypertensive patient outcomes are improved by establishing a holistic ecosystem around the patient journey.
With hypertension affecting a growing number of patients worldwide, the need for innovative solutions to better manage the condition has never been greater. Through this strategic partnership, OMRON Healthcare and Servier will work together to develop innovative solutions that will enable healthcare professionals to identify, manage and treat hypertension, with the ambition to reduce the number of cardiovascular events such as heart attacks and strokes more effectively.
The long-term partnership between OMRON Healthcare and Servier represents a significant step forward in the fight against cardiovascular disease. By working together to bring about innovative solutions, the two companies are poised to make a meaningful impact on the lives of millions of patients around the world.
The two companies have started collaborating on international projects, such as a screening program for hypertension, developed by the International Society of Hypertension that runs in May every year, and international webinars directed to Healthcare Professionals. Additionally, in several affiliates in countries around the world such as Italy and Poland, there are ongoing collaborations on developing medical education programs for HCPs aiming to improve the management of hypertension.
“OMRON Healthcare is committed to developing life-saving cardiovascular health technologies in pursuit of our Going for Zero vision to eliminate heart attacks and strokes. We need like-minded partners, like Servier, to advance our initiatives and work together to save lives,” says David Menko, CEO of OMRON Healthcare Europe.
Over one billion adults are hypertensive worldwide. The burden will grow significantly in the coming years due to an aging population and a growing number of heart diseases risk factors, such as diabetes, obesity, and high blood pressure.
“Our partnership with OMRON Healthcare will provide individuals and healthcare professionals with enhanced information and support to improve their management of patients suffering hypertension and other cardiovascular diseases; we will be in a position to provide an eco-system of solutions individualized to
the different patient's profiles along their journey as hypertensive,” says Dr. Philippe Gonnard, Executive Vice President Global Product Strategy of Servier.
Founded to serve health, Servier is a global pharmaceutical group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,400 employees of the Group are committed to this shared vocation, source of inspiration every day.
As a world leader in cardiology, Servier’s ambition is to become a renowned, focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 50% of its R&D budget to developing targeted and innovative therapies in oncology.
Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine.
To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.
In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.
Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €4.9 billion in 2022. More information on the new Group website: Servier.com
Follow Servieron social media: LinkedIn, Facebook, Twitter, Instagram
Media relations contact:
Sonia Marques: presse@Servier.com
About OMRON Healthcare
Committed to advance health and empower people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment.
Aiming to realize its vision “Going for Zero, Preventive Care for the Health of Society”, the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients to reduce cerebro-cardiovascular events, aggravation of respiratory diseases and restrictions due to chronic pain.
With well over 300 million units sold globally, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions and provides products and services in over 110 countries.
OMRON Healthcare Group is headquartered in Kyoto, Japan
OMRON HEALTHCARE Europe B.V.
Marketing and Communications Department
Scorpius 33, 2132 LR Hoofddorp, The Netherlands
Tel: +31-(0)23-554 4700